Miltenyi Biotec Receives FDA Approval for CliniMACSA CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia CAMBRIDGE, Mass.
http://ift.tt/1hrzuHb
http://ift.tt/1hrzuHb
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment